Global Computational Biology Market is expected to
reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%, according to a new study by Grand View
Research, Inc. Steady increase in the usage & application of
computational biology for bioinformatics R&D programs designed for
sequencing genomes to better understand biological systems and increasing
number of clinical studies in pharmacogenomics and pharmacokinetics for novel
drug discovery studies are expected to drive computational biology demand over
the next six years.
Computational
genomics for cellular and biological simulation applications dominated the
market in 2013, accounting for over 47% of global revenue. Key factors driving
demand for these applications include the growth of drug designing, disease
modeling and personalized medicine applications and the growing usage of
computational biology for functional and structural genomics, epigenomics and
metagenomics for the analysis of protein transcription, protein-protein
interactions, gene sequencing and expression and 3-dimensional protein
structure analysis.
Full Research Report on Global Computational
Biology Market Analysis:
http://www.grandviewresearch.com/industry-analysis/computational-biology-market
http://www.grandviewresearch.com/industry-analysis/computational-biology-market
Further key findings from the study
suggest:
- North America was the largest
regional market, accounting for 58.0% of the global revenue in 2013. Its
large share is majorly attributed to the growing research investments and initiatives
for development of drug discovery, disease modeling technologies and
innovations in biological computation methods. It is expected that Asia
Pacific will witness the fastest growth in the market, at an estimated
CAGR of 28.0% owing to the increasing expenditure in clinical studies for
pharmacokinetics and pharmacogenomics.
- The application of
computational biology in proteomics for cellular simulation is expected to
grow at the fastest CAGR of over 22% owing to the shift in sequencing
studies towards further analysis of the nature of various biological
proteins as a part of development of personalized medicine.
- Drug discovery and disease
modelling applications dominated the market, accounting for 58.0% of
global revenue in 2013. This large share is attributed by the extensive
drug development pipelines present for a number of global branded and
generic drug manufacturing firms such as Sanofi, Novo Nordisk and Eli
Lilly.
- Computational Biology
databases dominated the tools segment and accounted for 44.5% of the
market revenue in 2013, owing to extensive genomic database usage for
warehousing and data mining of biological and sequential data generated
from genomic and proteomic studies. Consequentially, the software and
services for the analysis of biological data is expected to witness the
fastest CAGR of over 21.0%.
- Key players of this market
include Schrodinger, Accelrys, Certara, Entelos, Simulation Plus and
others.
View more reports of this category by
Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the Global
Computational Biology Market on the basis of applications, tools, services, end
users and region:
Computational Biology Application
Outlook
- Cellular & Biological
Simulation
- Computational Genomics
- Computational Proteomics
- Pharmacogenomics
- Others
(Transcriptomics/Metabolomics)
- Drug Discovery and Disease
Modelling
- Target Identification
- Target Validation
- Lead Discovery
- Lead Optimization
- Preclinical Drug Development
- Pharmacokinetics
- Pharmacodynamics
- Clinical trials
- Phase I
- Phase II
- Phase III
- Human Body Simulation
Software
Computational Biology Tools Outlook
- Databases
- Infrastructure (Hardware)
- Analysis Software & Services
Computational Biology Services Outlook
- In-house
- Contract
Computational Biology End User Outlook
- Academics
- Industry
- Commercial
Computational Biology Regional Outlook
- North America
- Europe
- Asia Pacific
- RoW
View Press Release Of this research
report by Grand View Research: http://www.grandviewresearch.com/press-release/global-computational-biology-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment